Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. (Q40150524)
Jump to navigation
Jump to search
scientific article published on April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. |
scientific article published on April 2007 |
Statements
1 reference
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1. (English)
1 reference
Ramzi M Mohammad
1 reference
Anton Scott Goustin
1 reference
Amro Aboukameel
1 reference
Ben Chen
1 reference
Sanjeev Banerjee
1 reference
Guoping Wang
1 reference
Zaneta Nikolovska-Coleska
1 reference
Shaomeng Wang
1 reference
Ayad Al-Katib
1 reference
1 April 2007
1 reference
1 reference
13
1 reference
7
1 reference
2226-2235
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference